Ramelteon (CAS 196597-26-9) is a high-purity selective melatonin receptor agonist hypnotic API, engineered to treat insomnia with a physiological sleep-inducing mechanism. Its molecular structure specifically binds to MT1/MT2 receptors in the brain’s suprachiasmatic nucleus, regulating the sleep-wake cycle without interacting with GABA receptors, eliminating addiction and abuse risks. Produced under GMP-compliant processes, it ensures ultra-high purity, consistent bioactivity, and compliance with international pharmaceutical standards for sleep medications.